Jaguar Health, Inc. - Chronological SEC Filings

Search Ctrl + K

Jaguar Health, Inc.

Pharmaceutical Preparations

NASDAQ.JAGX

200 Pine Street Suite 400, San Francisco, CA, 94104

- Categorized
- Chronological
- Ownership by Owner
- Insider Transactions
- Institutional Owners
- Filings by Form Type
- Transcripts
- Your Highlights
- Articles & Bylaws
- Indentures
- Material contracts
- Plans of Reorganization
- Underwriting Agreements
- Google Finance
- SEC EDGAR

© 2023 Gheko, Inc. Terms of Service Privacy Policy Browse Companies

Latest Filings – Ownership

Bochnowski James J

Jayasuriya Anula

Wolin Jonathan S.

Chaturvedi Pravin R

Siegel Jonathan B.

Wolin Jonathan S.

Chaturvedi Pravin R

Wolin Jonathan S.

Chaturvedi Pravin R

Latest Filings – Non-Ownership

Entry Into A Material Definitive Agreement, Financial Statements And Exhibits

Quarterly Filing

Prospectus Filed Pursuant To Rule 424(b)(5).

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.

Quarterly Filing

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Regulation Fd Disclosure, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Financial Statements And Exhibits

Prospectus Filed Pursuant To Rule 424(b)(5).

Unregistered Sales Of Equity Securities, Financial Statements And Exhibits

Other Events, Financial Statements And Exhibits

Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Financial Statements And Exhibits

Unregistered Sales Of Equity Securities, Financial Statements And Exhibits

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

Scanned Paper Annual Report Submission.

Entry Into A Material Definitive Agreement, Material Modifications To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Financial Statements And Exhibits

Prospectus Filed Pursuant To Rule 424(b)(5).

Registration Statement Under The Securities Act.

Quarterly Filing